- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01111708
Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa(CU) (CR-IPAA)
April 26, 2010 updated by: University Medical Center Nijmegen
Clinical Outcome After Close Rectal Ileo Pouch Anal Anastomosis for Colitis Ulcerosa Compared to the Ileo Neo Rectal Anastomosis and the Ileo Pouch Anal Anastomosis
The purpose of this study is to investigate a new technique: Close Rectal Dissection (CRD) as restorative surgery for Ulcerative Colitis patients: the Close Rectal Ileo Pouch Anal Anastomosis (CR-IPAA).
Clinical outcome and quality of life will be compared to the conventional Ileo Pouch Anal Anastomosis (C-IPAA) and the Ileo Neo Rectal Anastomosis (INRA).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Ulcerative colitis (UC) is characterized by recurring episodes of inflammation limited to the mucosal layer of the colon.
The surgery rate after 10 years is 30%.
After (sub)total colectomy with end ileostoma patients have a choice for restorative surgery.
The conventional ileo pouch anal anastomosis (C-IPAA) is the gold standard of reconstructive surgery.
This is al well established technique, but still carries a significant morbidity-rate.
The recent studied ileo neo rectal anastomosis (INRA) has shown to reduce reservoir-related complications with a similar functional outcome, but is a very laborious technique.
Therefore, we want to investigate an alternative technique: the Close Rectal Ileo Pouch Anal Anastomosis (CR-IPAA).
The CR-IPAA is conducted in the nonanatomic perimuscular plane, resulting in a reduction of reservoir-related complications.
After the close rectal dissection an ileo-anal pouch anastomosis will be constructed in a similar way.
The close rectal dissection (CRD) is very laborious and has therefore never been developed extensively.
But recent technical development of electrothermal bipolar vessel sealer (EBVS ) and ultrasound dissection have enhanced the CRD technique enormously.
This brought along new interest in the CRD and justifies the research of its application.
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6500HB
- Recruiting
- Universitair Medical Centre St. Radboud
-
Contact:
- Sharonne de Zeeuw, Drs
- Phone Number: 0031-24-3616421
- Email: s.dezeeuw@chir.umcn.nl
-
Principal Investigator:
- Sharonne de Zeeuw, Drs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- UC patients with the CRD procedure with written informed consent.
- Age, sex and disease specific matched control group op UC-IPAA patients with written informed consent.
Exclusion Criteria:
- Pregnancy
- Malignancy
- Psychiatric disease or inability to assess follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Close Rectal-Ileo Pouch Anal Anastomosis
|
Comparison between conventional IPAA and Close Rectal IPAA and INRA after (sub)total proctocolectomy for Ulcerative colitis
Other Names:
|
|
Active Comparator: Conventional Ileo Pouch Anal Anastomosis
|
Comparison between conventional IPAA and Close Rectal IPAA and INRA after (sub)total proctocolectomy for Ulcerative colitis
Other Names:
|
|
Active Comparator: Ileo Neo Rectal Anastomosis
|
Comparison between conventional IPAA and Close Rectal IPAA and INRA after (sub)total proctocolectomy for Ulcerative colitis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine the clinical outcome (functional outcome and morbidity) after CR-IPAA compared to C-IPAA and INRA and to compare quality of life in these three different groups.
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Secondary objectives are the inflammatory responses (pouchitis), ano-rectal function, meso-rectal development on MRI, endoscopy results and histopathology.
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Kees v Laarhoven, prof. dr., Radboud University Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Anticipated)
April 1, 2013
Study Completion (Anticipated)
April 1, 2013
Study Registration Dates
First Submitted
April 26, 2010
First Submitted That Met QC Criteria
April 26, 2010
First Posted (Estimate)
April 27, 2010
Study Record Updates
Last Update Posted (Estimate)
April 27, 2010
Last Update Submitted That Met QC Criteria
April 26, 2010
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Close Rectal - IPAA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ulcerative Colitis
-
Odyssey TherapeuticsRecruitingUlcerative Colitis (UC) | UC - Ulcerative ColitisAustralia, Austria, Jordan, Poland, Ukraine, New Zealand, Canada, Czechia, Lithuania, Moldova
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; MRSU 938 - Research Center of Saint...Not yet recruitingPediatric Ulcerative Colitis in RemissionFrance
-
Ferring PharmaceuticalsCompletedActive Ulcerative Colitis | Remission of Ulcerative ColitisCanada
-
Rise Therapeutics LLCUniversity of Colorado, Denver; Mayo ClinicRecruitingUlcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic MildUnited States
-
Palatin Technologies, IncActive, not recruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute | UlcerativeUnited States
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
Eli Lilly and CompanyRecruitingUlcerative Colitis, Active Severe | Ulcerative Colitis (UC) | Ulcerative Colitis, Active ModerateUnited States, China, Croatia, France, India, Japan, Israel, Taiwan, Brazil, Serbia, Greece, Hungary, Argentina, Italy, Poland, Czechia, Colombia, Lithuania, Latvia, Ukraine, South Africa, Portugal, Mexico, Canada, Slovakia, Turkey (Türkiye) and more
-
Merck Sharp & Dohme LLCRecruitingUlcerative Colitis | Colitis UlcerativeUnited States
-
InventisBio Co., LtdRecruitingModerately to Severely Active Ulcerative Colitis | UC - Ulcerative ColitisChina
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedDisease Activity | Ulcerative Colitis Flare | Remission of Ulcerative ColitisTurkey
Clinical Trials on Close Rectal Dissection - IPAA
-
Philips HealthcarePhilips Electronics Nederland B.V. acting through Philips CTO organizationCompletedMalignant Lymphoma of Lymph Nodes of Inguinal Region | Malignant Lymphoma of Lymph Nodes of Axillary | Malignant Lymphoma of Lymph Nodes of the Cervix | Carcinoma of Parotid Gland | Colon Rectal Cancer Tubulovillous Adenocarcinoma | Tumor of Soft Tissue of Head, Face and NeckNetherlands
-
the BELOOSTROV Clinic of High TechnologiesNot yet recruitingOncology | Colorectal Cancer (CRC) | Surgery, ColorectalRussian Federation
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; Guangdong Provincial Hospital of Traditional... and other collaboratorsNot yet recruitingColorectal Neoplasms | Fluorescence | Lymph Node ExcisionChina